/Investor DB

BioStar Capital — Full Portfolio

6 tracked investments · listed companies and verified rows first

Amplitude Vascular Systemsavspulse.comin𝕏Oct 2022✓ verified

AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.

BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US

Robert Chisena, Ph.D.(Co-Founder & Chief Technology Officer)Andrew Casey(Executive Officer)inSean Gilligan(Executive Officer)inMark Toland(Executive Officer, Director)Hitinder Gurm, M.D.(Chief Clinical Officer)Robert Chisena(Executive Officer)

Board seatWilliam H. (Hank) KuchemanHank Kucheman· per SEC Form D

Co-investorsCorewell Health VenturesID Ventures

Medical Micro Instrumentsmmimicro.comin𝕏Feb 2024✓ verified

MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.

HealthtechMedical DevicesRoboticsJacksonville, US

Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)

Co-investorsAndera PartnersDeerfield Management CompanyFidelity InvestmentsRA CapitalCorewell Health VenturesFountain Healthcare Partners

XLERATEHEALTH, LLCxleratehealth.comin𝕏✓ verified

XLerateHealth supports healthcare innovation by providing resources and mentorship to startups in the sector, with a focus on regional development in the Midwest and Southeast.

BiotechDigital HealthEnterprise SoftwareHealthtechSector AgnosticLouisville, US

Bob Saunders(Chairman & Co-founder)inTed Smith(Co-founder)Jackie Willmot(CEO & Co-founder)Bobby Ferreri

Co-investorsChrysalis VenturesOCA VenturesRender Capital

Foldaxfoldax.comin𝕏Jun 2020

Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.

Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US

Frank Maguire(Executive Officer, Director)

BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)

Co-investorsAngel Physicians FundKairos Venture Investments, LlcMemorialCare Innovation FundBioStar VenturesKairos Venture PartnersSUMMATION HEALTH VENTURES

Nectero Medicalnecteromedical.comin

Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field.

BiotechHealthtechMedical DevicesDover, US

Jack Springer(President & CEO)inBruce Roberts(Director)in

Co-investorsAlumni VenturesAphelion CapitalCorewell Health VenturesNorwest Venture Partners

Versa Vascularversavascular.cominDec 2025 · $27.3M

Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.

HealthtechMedical DevicesSanta Cruz, US

Co-investorsCorewell Health VenturesSanta Cruz VentureView VenturesCadence Healthcare VenturesS3 Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.